This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Singapore, Turkey, United Kingdom, United States
The drug PARSABIV contains one active pharmaceutical ingredient (API):
|
1
Etelcalcetide
UNII 72PT5993DU - ETELCALCETIDE HYDROCHLORIDE
|
|
Etelcalcetide is a synthetic peptide calcimimetic agent which reduces PTH secretion through binding and activation of the calcium-sensing receptor. Etelcalcetide is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| PARSABIV Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| H05BX04 | H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1733217, 1733228, 1733239, 1733240, 1733251, 1733262, 1733273, 1733284, 1733295, 1733307, 1733318, 1733329 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1161142002, 1161142006, 1161142010 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 035992, 448419, 588212 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61970183, 67061971, 69279221 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 343642, 344870, 344874 |
| Country: HK | Department of Health Drug Office | Identifier(s): 65657, 65658, 65659 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8104, 8121, 8122 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 045182019, 045182021, 045182033, 045182045, 045182058, 045182060, 045182072, 045182084, 045182096, 045182108, 045182110, 045182122 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3999443A1025, 3999443A2021, 3999443A3028, 3999443G1028, 3999443G2024, 3999443G3020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1081609, 1081610, 1081611, 1081612, 1081613, 1081614, 1081615, 1081616, 1081617, 1081618, 1081619, 1081620 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 137480, 137499, 137502 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100381915, 100381921, 100381938 |
| Country: SG | Health Sciences Authority | Identifier(s): 15450P, 15451P, 15452P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699862770033, 8699862770040, 8699862770057, 8699862770064, 8699862770071, 8699862770088, 8699862770095, 8699862770101, 8699862770118 |
| Country: US | FDA, National Drug Code | Identifier(s): 55513-740, 55513-741, 55513-742 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
